ScinoPharm Taiwan, Ltd. (1789.TW) TAI
20.05
+0(+0.00%)
Currency In TWD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 13.49B |
| Enterprise Value | 11.15B |
| P/E Ratio | 154.97 |
| PEG Ratio | -2.67 |
| Price/Sales Ratio | 5.08 |
| Price/Book Ratio | 1.61 |
| Enterprise/Revenue | 4.31 |
| Enterprise/EBITDA | 21.59 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.03 |
| Operating Margin | 0.02 |
Management Effectiveness
| Return On Assets | 0.01 |
| Return On Equity | 0.01 |
Income Statement
| Revenue | 3.16B |
| Revenue/Share | 3.8 |
| Gross Profit | 1.1B |
| EBITDA | 673.97M |
| Net Income | 136.95M |
| Diluted EPS | 0.17 |
Balance Sheet
| Total Cash | 3.27B |
| Total Cash/Share | 3.95 |
| Total Debt | 862.29M |
| Total Debt/Equity | 0.08 |
| Current Ratio | 6.55 |
| Book Value Per Share | 12.48 |
Price History
| 52-Week Change | 15.14 |
| 52-Week High | 29.1 |
| 52-Week Low | 16.25 |
| Moving Average 50 Days | 20.4 |
| Moving Average 200 Days | 19.89 |
Statistics
| Average Volume | 1.06M |
| Shares Outstanding | 790.74M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.35 |
| Trailing Annual Dividend Yield | 1.74 |
| Payout Ratio | 2.58 |
| Last Split Factor | 26:25 |
| Last Split Date | August 10, 2017 |
